Y-Intercept (HK)’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Y-Intercept (HK)'s AXSM Position: Q3 2026 in Review
Y-Intercept (HK) reduced its Axsome Therapeutics (AXSM) stake by 38% in Q3 2026, selling an estimated $1.88M and leaving 14,293 shares worth $2.64M. The position accounts for 0.06% of the portfolio, ranked #486.
Y-Intercept (HK) first reported a position in AXSM in Q4 2020 and has held it in 13 quarters since. The position peaked at $6.37M in Q4 2025. 49 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Y-Intercept (HK) held 14,293 shares of Axsome Therapeutics worth $2.64M as of Q3 2026.
- Y-Intercept (HK) sold 8,630 Axsome Therapeutics shares in Q3 2026, an estimated $1.88M.
- Axsome Therapeutics made up 0.06% of Y-Intercept (HK)'s portfolio in Q3 2026, its #486 holding.
- Y-Intercept (HK) first reported a position in Axsome Therapeutics in Q4 2020 and has held it in 13 quarters since.
- Y-Intercept (HK)'s Axsome Therapeutics position peaked at $6.37M in Q4 2025.
- 49 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.